StockWatch
·
EUREKA FORBES LTD · QQ1 FY-2027 · THE CALL

Strong growth masks profit shortfall; margin maintained, not raised

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsEUREKAFORBEureka Forbes Ltd19 Aug 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Pre-exceptional PAT growth 6.1% vs revenue 15.2% signals execution gap. Guidance maintained (not raised) despite 15% growth.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Q1 delivered solid 15% revenue growth, but pre-exceptional PAT growth of only 6.1% reveals weak profit leverage. Despite cost headwinds and margin compression (-46 bps EBITDA, -131 bps gross), management maintains (not raises) FY27 margin guidance, suggesting limited upside near-term. Long-term 2x revenue/3x EBITDA targets by FY30 are credible (emerging categories, D2C, innovations), but profit execution risk remains the key constraint.

₹700.4 Cr

Revenue · +15.2% YoY

₹57 Cr

Reported PAT · +47.3% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Revenue grew 15.3% YoY to ₹701 Cr

MET

Delivered ₹700.4 Cr, 15.2% YoY growth

Water purifier grew by high teens with double-digit volume growth

MET

Product business high-teens growth confirmed; exact water purifier % not separately disclosed by company

Adjusted EBITDA margin 10.5%, down 46 bps YoY with higher growth investments

MET

Confirmed; also noted gross margin down 131 bps from commodity/forex impact

Pre-exceptional PAT grew 6.1% YoY to ₹41 Cr

MET

Reported PAT ₹55 Cr includes ₹19.5 Cr one-time gratuity reversal gain. Pre-exceptional ₹41 Cr = 6.1% growth only

Service revenue growth in line with past quarters despite 3-12% price hike

MET

Confirmed; bookings softer due to customer deferrals. Service revenue growth ~2.7% in absolute terms

Market share gains in water despite competitive intensity

MET

Management stated market share gained, but no external data to verify; organic growth vs supply-constrained competitors

Earnings quality

What changed since the last call

Deltas vs. the prior call

Margin guidance: hold, not expand

Maintained

Prior FY26 guidance said hold margins in FY27 despite cost inflation. Current call reaffirms 'broadly in line with last year.' No margin expansion target despite 15% revenue growth.

Service growth deflated post-pricing

Downgrade

Prior calls implied double-digit service growth. Q1: service revenue ~2.7% growth; bookings deferred due to 3-12% AMC price hike. Normalization expected but timeline uncertain.

Cost environment: no relief visibility

Neutral

Management states 'cost environment remains challenging, yet to see meaningful reduction in input costs.' Commodities, forex, geopolitics ongoing. Efficiency programs the only lever.

Emerging categories thrust intensified

Upgrade

Robotics, softeners, air purifiers all growing ahead of average. Robotics ₹1,000 Cr ambition by FY30 (up from early-stage). New campaign featuring Shraddha Kapoor launched.

D2C momentum sustained

New

2.5M monthly active users, strong growth. Cross-sell to 15M customer base underway. Low multi-category ownership (<1%) creates upside.

The Q&A

Moderate. Analysts pressed on service weakness (deferral vs loss), pricing strategy amid cost inflation, and margin sustainability. Management defended: service deferral temporary (18-month lag effect), pricing calibrated to protect growth momentum, margin maintenance achievable via efficiency + operating leverage. No major evasions, but lack of numeric commitments on near-term PAT growth.

The exchanges that mattered

Service growth pressure — Siddhartha Bera, Nomura

Partial

Service bookings deferred due to price hike; expect normalization over time. Filter business growth compensating. Deferred liability from prior multiyear AMCs to benefit FY27 revenue.

Pricing strategy and cost coverage — Siddhartha Bera, Nomura

Answered

Calibrated, measured approach. While not covering 100% of cost increase in percentage terms, covered in absolute terms. Focus on efficiency, cost savings programs, portfolio mix.

A&SP spend breakdown — Siddhartha Bera, Nomura

Partial

Don't break out by quarter. Almost entire increase is A&SP, largely in-store presence and retail visibility investments.

Growth composition (price vs volume) — Keshav Lahoti, HDFC Securities

Answered

Water: double-digit volume growth with some price impact. Robotics: mix shift to premium (premiumization). Softeners: volume-led. Overall broad-based, volume-led.

Service double-digit guidance withdrawn — Keshav Lahoti, HDFC Securities

Dodged

Two drivers: AMC and filters. Bookings softer but filters growing well. Timeline for double-digit recovery depends on bookings and filter scaling.

Filter life innovation response — Umang Mehta, Kotak Securities

Answered

We were first to 2-year, then 4-year (45 days ago). Focus on TCO reduction and category growth. 70% of 2-year customers are first-time entrants.

A&SP spend guidance — Achal Lohade, Nuvama

Partial

Don't disclose quarterly breakout. Expect A&SP ahead of revenue growth for full year. Focused on in-store presence and consumer finance adoption.

Service liability and margin impact — Achal Lohade, Nuvama

Answered

Liability helps FY27 revenue. Softer bookings help service charges somewhat but not large profitability impact. Filters slightly lower margin than AMC but still high GM.

Market share gains organic? — Sameer Gupta, IIFL Capital

Answered

No supply constraint benefit. Competitive field. Gained share via strong consumer propositions, point-of-sale investments, disciplined execution.

Margin trajectory FY27 — Sameer Gupta, IIFL Capital

Answered

Q1 conscious upfront investment in growth. Multiple workstreams on COGS and opex efficiency. Operating leverage from higher growth. Prior year started -46 bps, ended +55 bps expansion.

FY30 revenue growth mix — Vikram Kotak, Ace Lansdowne

Answered

Product and emerging categories growing ahead of average. Service (AMC + filters) also part of 2x. Filters large TAM with upside. Mix may shift.

Robotics 3-year outlook — Vikram Kotak, Ace Lansdowne

Answered

Analogous to washing machines 25-30 years ago. Full portfolio (₹15k–₹1L), India-specific features, service network moat, brand equity, D2C database, offline presence all key advantages.

FY30 revenue split across segments — Mayur Parkeria, Wealth Managers

Partial

Water core, emerging categories (robotics, air, softeners) ahead of average. Service includes AMC + filters; filters to grow ahead of AMC. Overall 2x.

FY27 margin expansion vs 50 bps annual plan — Mayur Parkeria, Wealth Managers

Answered

Last 3 years margins consistently improved. This year unusual (commodity, forex, geopolitics). Holding margins is good outcome. Next year bigger scale allows make-up.

Competitive defense strategy — Anjali Mohata, Melania Family Office

Answered

More competition grows category. Focus on affordability (entry + TCO), premiumization, innovation. Category leader mandate is consumer-obsessed, not competitor-focused.

Historical growth rate vs aggressive targets — Anjali Mohata, Melania Family Office

Answered

FY23 had little category growth. FY24 onwards initiatives (affordable Aquaguard, awareness) drove acceleration. Category accelerating. Product growth to exceed 17-18% overall target.

Operational efficiency plans — Anjali Mohata, Melania Family Office

Answered

Focused, deliberate planned intervention on waste reduction and efficiency. Clinical review of all costs. Using technology, data, AI to find efficiency gains.

Guidance

Forward guidance and management's confidence

FY27: clear step-up in growth vs FY26 baseline

Medium

Specific number not provided. Q1 at 15.2% sets pace. Depends on service recovery and emerging category scale.

FY30: 2x revenue vs FY25 (CAGR 17-18%)

High

Reaffirmed multiple times. Product categories (esp. water, robotics, softeners, air) to grow ahead of average.

FY27 EBITDA margins: broadly in line with FY26

Medium

Maintain, not expand. Q1 down 46 bps YoY; expects recovery in later quarters via operating leverage + efficiency programs.

FY30: 3x EBITDA vs FY25

Medium

Contingent on revenue growth + margin leverage. Currently PAT growth lagging revenue; profit execution risk present.

Risks the call surfaced

Ranked by how much they should concern a holder

Service revenue pressure

High

Service bookings softer post 3-12% AMC price hike. Customers deferring renewals. Recovery timeline tied to 18-month AMC tenure lag.

Gross margin compression

High

Gross margin down 131 bps YoY to 58.4% due to commodity costs and adverse currency movements. Cost environment 'challenging' with 'no meaningful reduction expected.'

Profit leverage risk

Medium

Pre-exceptional PAT growth only 6.1% vs revenue 15.2%. Despite 15% revenue growth, PAT severely lagging. Margin guidance to 'hold' (not expand) suggests limited near-term profit upside.

Pricing power constrained

Medium

Management states will NOT raise prices further despite cost inflation. Peers matched Q1 price hike with ~30-day lag; 'price equilibrium' now restored. Bias toward growth over margin protection.

Emerging category scaling risk

Medium

Robotics, air purifiers, softeners still nascent (low base). Management targets ₹1,000 Cr robotics by FY30 (5-year CAGR ~40%+). Ambitious. Competitive entry likely as market grows.

Management

Score 7/10. Clear on strategy and long-term vision. Candid on near-term headwinds (service deferral, cost inflation). Avoided specific near-term PAT targets; focused on 'step-up' language. Q&A responses detailed, generally direct. FY26 track record positive: started with -46 bps margin, ended with +55 bps expansion. Q1 FY27 revenue 15.2% on target, but pre-exceptional PAT only 6.1% signals execution gap on profit. Service bookings weak as flagged.

What to watch next
  • 1 · Q2-Q3 FY27

    Service bookings normalization post price-hike deferral window

  • 2 · FY28

    Emerging categories (robotics, softeners) scaling to higher base; margin leverage from volume

  • 3 · Near-term

    Commodity/forex headwinds persist; no relief expected in FY27

Long-term 2x revenue/3x EBITDA targets by FY30 are credible (emerging categories, D2C, innovations), but profit execution risk remains the key constraint.

Informational and educational content only. Not investment advice.